Structural diversity, evolutionary origin, and metabolic engineering of plant specialized benzylisoquinoline alkaloids
Top Cited Papers
- 3 October 2024
- journal article
- review article
- Published by Royal Society of Chemistry (RSC) in Natural Product Reports
- Vol. 41 (11) , 1787-1810
Abstract
Covering: up to June 2024 Benzylisoquinoline alkaloids (BIAs) represent a diverse class of plant specialized metabolites derived from L-tyrosine, exhibiting significant pharmacological properties such as anti-microbial, anti-spasmodic, anti-cancer, cardiovascular protection, and analgesic effects. The industrial production of valuable BIAs relies on extraction from plants; however, challenges concerning their low concentration and efficiency hinder drug development. Hence, alternative approaches, including biosynthesis and chemoenzymatic synthesis, have been explored. Model species like Papaver somniferum and Coptis japonica have played a key role in unraveling the biosynthetic pathways of BIAs; however, many aspects, particularly modified steps like oxidation and methylation, remain unclear. Critical enzymes, e.g., CYP450s and methyltransferases, play a substantial role in BIA backbone formation and modification, which is essential for understanding the origin and adaptive evolution of these plant specialized metabolites. This review comprehensively analyzes the structural diversity of reported BIAs and their distribution in plant lineages. In addition, the progress in understanding biosynthesis, evolution, and catalytic mechanisms underlying BIA biosynthesis is summarized. Finally, we discuss the progress and challenges in metabolic engineering, providing valuable insights into BIA drug development and the sustainable utilization of BIA-producing plants.Keywords
Funding Information
- National Natural Science Foundation of China (82204577)
- National Natural Science Foundation of China (82274037)
- National Natural Science Foundation of China (82360754)
- National Natural Science Foundation of China (U23A20511)
- National Key Research and Development Program of China (2023YFC3504800)
This publication has 159 references indexed in Scilit:
- Lineage‐Specific CYP80 Expansion and Benzylisoquinoline Alkaloid Diversity in Early‐Diverging EudicotsAdvanced Science, 2024
- Pharmacokinetic of berberine, the main constituent of Berberis vulgaris L.: A comprehensive reviewPhytotherapy Research, 2022
- Construction of ajmalicine and sanguinarine de novo biosynthetic pathways using stable integration sites in yeastBiotechnology and Bioengineering, 2022
- Development of an artificial biosynthetic pathway for biosynthesis of (S)‐reticuline based on HpaBC in engineered Escherichia coliBiotechnology and Bioengineering, 2021
- Synthesis of Morphinans through Anodic Aryl‐Aryl CouplingThe Chemical Record, 2021
- PR10/Bet v1‐like Proteins as Novel Contributors to Plant Biochemical DiversityChemBioChem, 2020
- Berberine induces resistance against tobacco mosaic virus in tobaccoPest Management Science, 2019
- Structure and Biocatalytic Scope of Coclaurine N‐MethyltransferaseAngewandte Chemie International Edition, 2018
- Identification and metabolite profiling of alkaloids in aerial parts of Papaver rhoeas by liquid chromatography coupled with quadrupole time‐of‐flight tandem mass spectrometryJournal of Separation Science, 2018
- Identification and analysis of alkaloids in cortex Phellodendron amurense by high‐performance liquid chromatography with electrospray ionization mass spectrometry coupled with photodiode array detectionJournal of Separation Science, 2014